Litcius/Paper detail

Fusion of shallow and deep features from 18F-FDG PET/CT for predicting EGFR-sensitizing mutations in non-small cell lung cancer

Xiaohui Yao, Yuan Zhu, Zhenxing Huang, Yue Wang, Shan Cong, Liwen Wan, Ruodai Wu, Long Chen, Zhanli Hu

2024Quantitative Imaging in Medicine and Surgery45 citationsDOIOpen Access PDF

Abstract

Background: Non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor-sensitizing (EGFR-sensitizing) mutations exhibit a positive response to tyrosine kinase inhibitors (TKIs). Given the limitations of current clinical predictive methods, it is critical to explore radiomics-based approaches. In this study, we leveraged deep-learning technology with multimodal radiomics data to more accurately predict EGFR-sensitizing mutations. Methods: F-FDG PET/CT) scans and EGFR sequencing prior to treatment were included in this study. Deep and shallow features were extracted by a residual neural network and the Python package PyRadiomics, respectively. We used least absolute shrinkage and selection operator (LASSO) regression to select predictive features and applied a support vector machine (SVM) to classify the EGFR-sensitive patients. Moreover, we compared predictive performance across different deep models and imaging modalities. Results: . 0.38. Additionally, the receiver operating characteristic (ROC) curves of the model using both deep and shallow features were significantly different from those of the model built using only shallow features (P<0.05). Conclusions: Our findings suggest that deep features significantly enhance the detection of EGFR-sensitizing mutations, especially those extracted with ResNet. Moreover, PET/CT images are more effective than CT-only and PET-only images in producing EGFR-sensitizing mutation-related signatures.

Topics & Concepts

Epidermal growth factor receptorRadiomicsLung cancerMedicineCancer researchTyrosine kinaseOncologyMutationCancerComputational biologyInternal medicineReceptorBiologyRadiologyGeneGeneticsRadiomics and Machine Learning in Medical ImagingLung Cancer Diagnosis and TreatmentCancer Immunotherapy and Biomarkers